Szerző: 
															
Nizar Bahlis, MD1
															Thierry Facon, MD2
															Saad Z. Usmani, MD3
															Shaji K. Kumar, MD4
															 Torben Plesner, MD, DSc5
															Robert Z. Orlowski, MD, PhD6
															Cyrille Touzeau, MD7
															Supratik Basu, MBBS, MD, FRCP, FRCPath8
															Hareth Nahi, MD, PhD9
															Cyrille Hulin, MD10
															Hang Quach, MD11
															Hartmut Goldschmidt12
															Michael E O'Dwyer, MD13
															Christopher P Venner, MD14
															Katja C. Weisel, MD15
															Maria Krevvata, PhD16
															Huiling Pei, PhD17
															Jianping Wang18
															Rian Van Rampelbergh19
															Jon Ukropec, PhD20
															Clarissa M. Uhlar21
															Rachel Kobos, MD22
															Aurore Perrot23
														
							
							
																
									1University of Calgary, Arnie Charbonneau Cancer Institute, Calgary, AB, Canada
																								
									
2Service des Maladies du Sang, Hôpital Claude Huriez, Lille, France
																								
									
3Levine Cancer Institute/Atrium Health, Charlotte, NC
																								
									
4Division of Hematology, Mayo Clinic, Rochester, MN
																								
									
5Vejle Hospital and University of Southern Denmark, Vejle, Denmark
																								
									
6Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
																								
									
7Hematology, University Hospital Hôtel-Dieu, Nantes, France
																								
									
8Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, United Kingdom
																								
									
9Karolinska Institute, Department of Medicine, Division of Hematology, Karolinska University Hospital at Huddinge, Stockholm, Sweden
																								
									
10Department of Hematology, Hôpital Haut Lévêque, University Hospital, Pessac, France
																								
									
11St. Vincent's Hospital, Melbourne, Australia
																								
									
12University Hospital Heidelberg and National Center of Tumor Diseases (NCT), Heidelberg, Germany
																								
									
13Dept. of Medicine/Haematology, NUI, Galway, Ireland
																								
									
14Division of Medical Oncology, University of Alberta, Edmonton, AB, Canada
																								
									
15Medical Center of Hamburg-Eppendorf, Hamburg, Germany; University of Tuebingen, Tuebingen, Germany
																								
									
16Janssen Research & Development, LLC, Spring House, PA
																								
									
17Janssen Research & Development, LLC, Titusville, NJ
																								
									
18Janssen Research & Development, LLC, Raritan, NJ
																								
									
19Janssen Research & Development, Beerse, Belgium
																								
									
20Janssen Global Medical Affairs, Horsham, PA
																								
									
21Janssen Research & Development, LLC, Spring House, PA
																								
									
22Janssen Research & Development, LLC, Raritan, NJ
																								
									
23Hematology Department, University Hospital, Vandoeuvre Les Nancy, France